Atlas Trials

Standard Versus High-Dose Trivalent Inactivated Flu Vaccine in Pediatric Acute Lymphoblastic Leukemia Patients

Clinical trial NCT01216332 · COMPLETED

Trial details

NCT number
NCT01216332
Sponsor
Vanderbilt University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pediatric Patients With Acute Lymphoblastic Leukemia
Start date
2010-10-01
Primary completion
2013-05-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.